Vitasora Health (VHLUF) Ratios

5 Followers

Vitasora Health Ratios

VHLUF's free cash flow for Q3 2025 was AU$7.36. For the 2025 fiscal year, VHLUF's free cash flow was decreased by AU$ and operating cash flow was AU$-0.78. See a summary of the company’s cash flow.

Ratios	TTM	Jun 25	Jun 24	Jun 23	Jun 22
Liquidity Ratios
Current Ratio	―	2.90	1.18	1.34	3.44
Quick Ratio	―	1.89	0.37	0.79	1.23
Cash Ratio	―	1.16	0.22	0.07	1.02
Solvency Ratio	―	-3.46	-1.99	-2.42	-5.46
Operating Cash Flow Ratio	―	-3.79	-1.94	-2.01	-7.08
Short-Term Operating Cash Flow Coverage	―	0.00	-5.64	0.00	0.00
Net Current Asset Value	AU$ ―	AU$ 4.93M	AU$ 480.46K	AU$ 650.56K	AU$ 2.93M
Leverage Ratios
Debt-to-Assets Ratio	―	0.00	0.21	0.05	0.02
Debt-to-Equity Ratio	―	0.00	0.49	0.18	0.02
Debt-to-Capital Ratio	―	0.00	0.33	0.15	0.02
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.17	2.35	3.85	1.40
Debt Service Coverage Ratio	―	0.00	-5.64	-342.15	0.00
Interest Coverage Ratio	―	0.00	-117.60	-423.46	0.00
Debt to Market Cap	―	0.00	0.04	0.00	0.00
Interest Debt Per Share	―	0.00	<0.01	<0.01	<0.01
Net Debt to EBITDA	―	0.31	-0.08	>-0.01	0.16
Profitability Margins
Gross Profit Margin	―	-137.33%	99.16%	-3468.34%	-747.68%
EBIT Margin	―	-261.35%	-1546.07%	-8166.80%	-2807.00%
EBITDA Margin	―	-232.05%	-1532.06%	-8057.22%	-2774.69%
Operating Profit Margin	―	-261.35%	-1673.36%	-9005.52%	-2818.30%
Pretax Profit Margin	―	-260.96%	-1560.30%	-8968.88%	-2806.99%
Net Profit Margin	―	-248.15%	-1560.30%	-8188.07%	-2611.20%
Continuous Operations Profit Margin	―	-248.15%	-1560.30%	-8188.07%	-2611.20%
Net Income Per EBT	―	95.09%	100.00%	91.29%	93.02%
EBT Per EBIT	―	99.85%	93.24%	99.59%	99.60%
Return on Assets (ROA)	―	-56.31%	-115.16%	-181.54%	-157.52%
Return on Equity (ROE)	―	-65.76%	-270.36%	-698.44%	-220.24%
Return on Capital Employed (ROCE)	―	-68.96%	-276.54%	-673.37%	-237.71%
Return on Invested Capital (ROIC)	―	-65.58%	-191.13%	-594.14%	-216.05%
Return on Tangible Assets	―	-138.88%	-171.73%	-181.54%	-157.52%
Earnings Yield	―	-52.43%	-26.95%	-18.94%	-16.55%
Efficiency Ratios
Receivables Turnover	―	2.59	1.95	1.49	5.04
Payables Turnover	―	5.48	<0.01	1.67	4.10
Inventory Turnover	―	3.82	<0.01	2.04	0.81
Fixed Asset Turnover	―	837.71	3.91	0.40	3.07
Asset Turnover	―	0.23	0.07	0.02	0.06
Working Capital Turnover Ratio	―	1.53	0.66	0.04	0.05
Cash Conversion Cycle	―	169.99	98.85K	204.31	433.33
Days of Sales Outstanding	―	140.99	186.97	244.48	72.38
Days of Inventory Outstanding	―	95.54	260.39K	178.62	449.98
Days of Payables Outstanding	―	66.55	161.73K	218.79	89.02
Operating Cycle	―	236.54	260.58K	423.10	522.35
Cash Flow Ratios
Operating Cash Flow Per Share	―	>-0.01	>-0.01	>-0.01	-0.01
Free Cash Flow Per Share	―	>-0.01	>-0.01	>-0.01	-0.01
CapEx Per Share	―	<0.01	0.00	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	―	-2.50M	0.00	-205.96	-3.74K
Capital Expenditure Coverage Ratio	―	-2.50M	0.00	-205.96	-3.74K
Operating Cash Flow Coverage Ratio	―	0.00	-5.14	-30.11	-119.97
Operating Cash Flow to Sales Ratio	―	-2.34	-14.54	-63.66	-33.42
Free Cash Flow Yield	―	-49.43%	-25.10%	-14.80%	-21.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.90	-3.71	-5.28	-6.04
Price-to-Sales (P/S) Ratio	―	4.73	57.91	432.21	157.82
Price-to-Book (P/B) Ratio	―	1.25	10.03	36.87	13.31
Price-to-Free Cash Flow (P/FCF) Ratio	―	-2.02	-3.98	-6.76	-4.72
Price-to-Operating Cash Flow Ratio	―	-2.02	-3.98	-6.79	-4.72
Price-to-Earnings Growth (PEG) Ratio	―	0.11	1.34	0.25	0.14
Price-to-Fair Value	―	1.25	10.03	36.87	13.31
Enterprise Value Multiple	―	-1.73	-3.86	-5.36	-5.52
Enterprise Value	―	17.18M	26.99M	30.49M	38.89M
EV to EBITDA	―	-1.73	-3.86	-5.36	-5.52
EV to Sales	―	4.02	59.07	432.25	153.30
EV to Free Cash Flow	―	-1.72	-4.06	-6.76	-4.59
EV to Operating Cash Flow	―	-1.72	-4.06	-6.79	-4.59
Tangible Book Value Per Share	―	<0.01	<0.01	<0.01	<0.01
Shareholders’ Equity Per Share	―	<0.01	<0.01	<0.01	<0.01
Tax and Other Ratios
Effective Tax Rate	―	0.05	<0.01	0.09	0.07
Revenue Per Share	―	<0.01	<0.01	<0.01	<0.01
Net Income Per Share	―	>-0.01	>-0.01	>-0.01	>-0.01
Tax Burden	―	0.95	1.00	0.91	0.93
Interest Burden	―	1.00	1.01	1.10	1.00
Research & Development to Revenue	―	0.09	0.30	5.36	5.77
SG&A to Revenue	―	1.10	15.19	71.52	18.46
Stock-Based Compensation to Revenue	―	0.00	1.18	4.76	1.66
Income Quality	―	0.94	0.93	0.78	1.28

Currency in AUD